ImmunityBio, Inc. - Common Stock - Mali Tablolar (NASDAQ:IBRX) | MetaTrader

Tam grafiği aç Full chart

Haberler

IBRX and the BCG Shortage: Deals That Could Expand Demand

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

Undercovered Stocks: Cerebras Systems, Infleqtion, Duos Technologies And More

ImmunityBio mesane kanseri hasta anketi verilerini sundu

ImmunityBio mesane kanseri tedavisi için maliyet analizi sundu

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

ImmunityBio hisseleri FDA’nın mesane kanseri başvurusunu kabul etmesiyle yükseldi

FDA, ImmunityBio’nun Anktiva başvurusunu kabul etti

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

ImmunityBio hisseleri beş yeni ABD patentiyle yükseldi